NASDAQ · NVDA
NVIDIA Corporation
$213.66-$1.72 (-0.8%)
NVIDIA Corporation’s quoted price sits in the upper half of its reported 52-week range, 12.21% below the high.
Loading market information…
NYSE · VEEV · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Veeva Systems Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.8% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Veeva Systems Inc.’s next earnings report is currently expected on Nov 25, 2026, with estimated earnings per share of $2.33. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Veeva Systems Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry. Its extensive operational presence spans across North America, Europe, the Asia Pacific region, the Middle East, Africa, and Latin America. The company's product portfolio is primarily structured around two major offerings. First, the Veeva Commercial Cloud delivers an integrated suite of software, data, and analytics tools designed to optimize commercial operations. This includes vital applications such as Veeva Customer Relationship Management (CRM) and its specialized Medical CRM, Veeva Closed Loop Marketing (CLM), sophisticated analytics via Veeva CRM MyInsights, approved email communication with Veeva CRM Approved Email, digital engagement tools like Veeva CRM Engage, commercial alignment through Veeva Align, event management capabilities with Veeva CRM Events Management, data warehousing solutions (Veeva Nitro), data services (Veeva OpenData, Veeva Link), master data management (Veeva Network), advanced analytical insights (Veeva Crossix, Veeva Data Cloud), and patient engagement platforms (MyVeeva for Patients). Secondly, Veeva Vault provides a robust collection of cloud-native enterprise content and data management applications. These applications are engineered to support both critical commercial functions—encompassing sales, marketing, and medical content and communications—and comprehensive research and development processes, including clinical trials, regulatory compliance, quality management, and patient safety. Beyond its software, Veeva offers a wide array of professional and support services. These range from strategic implementation and deployment planning, project management, and detailed requirements analysis to solution design and configuration. They also include system environment management and deployment, expert consulting for business process transformation related to Veeva solutions, technical guidance on data migration and systems integrations, comprehensive training programs, and ongoing managed services such as outsourced systems administration. Tracing its origins, the company was incorporated in 2007 as Verticals onDemand, Inc., and subsequently rebranded to Veeva Systems Inc. in April 2009. Its corporate headquarters are situated in Pleasanton, California.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:23 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2026 | May 28, 2025 | $1.97+13.22% vs estimate | $759.04M+4.21% vs estimate |
|---|
| Q4 2025 | Mar 5, 2025 | $1.74+8.75% vs estimate | $720.89M+3.1% vs estimate |
|---|
| Q3 2025 | Dec 5, 2024 | $1.75+10.76% vs estimate | $699.21M+2.17% vs estimate |
|---|
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
THE ANALYST VIEW
43 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 20 contributors · Median target $310.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$213.66-$1.72 (-0.8%)
NVIDIA Corporation’s quoted price sits in the upper half of its reported 52-week range, 12.21% below the high.
$348.91+$5.08 (+1.48%)
Apple Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.8% below the high.
$530.14-$0.87 (-0.16%)
Microsoft Corporation’s quoted price sits in the upper half of its reported 52-week range, 3.81% below the high.
$345.00-$6.81 (-1.94%)
Broadcom Inc.’s quoted price sits in the lower half of its reported 52-week range, 30.3% below the high.
$275.06-$3.98 (-1.43%)
IQVIA Holdings Inc.’s quoted price sits in the upper half of its reported 52-week range, 3.32% below the high.
$33.63-$0.62 (-1.81%)
Doximity, Inc.’s quoted price sits in the lower half of its reported 52-week range, 49.88% below the high.
$29.99-$0.88 (-2.85%)
Schrödinger, Inc.’s quoted price sits in the upper half of its reported 52-week range, 11.22% below the high.
$33.80+$0.07 (+0.21%)
HealthStream, Inc.’s quoted price sits in the upper half of its reported 52-week range, 5.08% below the high.
